CD34 and diabetes mellitus: Similarly, acid sphingomyelinase (ASM) activation in CD34+ reparative cells of diabetics is associated with their impaired functionality [29] and measurements of ASM activity can likewise be used to predict vascular repair capacity and vascular health in diabetics.